Group items tagged

AstraZeneca has made its social-media pitch to the FDA. In response to the agency's call for comments on new rules for online marketing and communications, the drugmaker outlined some ways interactions with customers--and potential customers--might be governed. Read more: http://www.fiercepharma.com/story/az-pitches-social-media-rules-fda/2010-03-02?utm_medium=nl&utm_source=internal#ixzz0h2feB1qq

Chris Atachison from the Globe and Mail reveals how Octane Medical Group, a biotechnology firm that makes regenerative medical products, analyzed an astronaut's health problem which led to their discover on how to help him med.

MaRS Innovation (MI) and the Centre for Drug Research and Development (CDRD) are pleased to announce that they have entered into an agreement to collaborate on projects of mutual interest with a goal to advance and commercialize early-stage health-related discoveries. Dec 15, 2009

Toronto's Baycrest centre is staking a claim to a piece of the booming brain fitness market with a new company, Cogniciti, and a new generation of brain games aimed at helping baby boomers keep their minds sharp and boost their productivity in the workplace well into old age. Alvaro Fernandez, a researcher on aging, says the new games are designed to keep older brains nimble. Hon. Milloy states "The McGuinty government is proud to support the work that both MaRS and Baycrest are doing to improve quality of life and tackle the challenges of an aging population. Ontario is supporting innovators across the province to ensure this kind of success is the rule, not the exception." Dec 2, 2009

To improve early detection and treatment of cancer, a pair of Toronto scientists, Dr David Jaffray, a senior scientist in the division of biophysics and bioimaging at the Ontario Cancer Institute and Dr Christine Allen, an associate professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto has developed a technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Dec 23, 2009

Tom Rand, Practice Lead, Cleantech and Physical Science Venture Group, MaRS, talks about the January 29, 2010, Green Energy Act Finance Forum, in Toronto, Ontario, Canada, designed to educate the financial community about new renewable energy investment opportunities, recorded from Toronto on January 7, 2010.

An article in OSBR by Lisa Torjman, Associate, SiG@MaRS and Jon Worren, Advisor, MaRS. The article talks about the factors contributing to the weak culture of entrepreneurship in Canada.

Vive Nano receives accolades for its clean tech approach. Its appeal is in its business model: to develop new processes and company-specific nanoparticles, then lease out their know-how to established companies who have both their own distribution networks and capability to deal with the various national regulatory hurdles that a small firm could never hope to manage.

MaRS client and Toronto nanotechnology upstart Vive Nano is featured in Yonge Street magazine as a good news story for innovative business in TO.

In 2009, the Chinese central government spent $18.75 billion on healthcare up 50 percent year over year. For 2010, spending is forecast at $20.36 billion, which would be an 8.8 percent increase year over year

The R&D investments by PhRMA members and non-members in the pharmaceutical and biotech sectors reached a record $65.3 billion in 2009, an increase of 1.5 billion despite the recession

A federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property

Good news for pharma&biotech, the drug market just got bigger!

Interest is booming in the use of mobile devices such as Apple's iPhone for image viewing applications. But that excitement may be dampened somewhat with a recent U.S. Food and Drug Administration (FDA) decision to classify an iPhone image viewing application as a class III device requiring premarket approval.

Google announces an addition to Google Labs - the Public Data Explorer. The purpose of the new tool, Google says on the new lab's page, "The Google Public Data Explorer makes large datasets easy to explore, visualize and communicate

On April 1, to commemorate the 3rd United Nations-sanctioned World Autism Awareness Day will be taking place at the MaRS Centre in Toronto.

An international study based at the University of Pittsburgh has identified a human enzyme that can biodegrade carbon nanotubes. Laboratory tests showed that it could also offset the potentially damaging health effects of being exposed to such nanotechnology.

The 2010 Canada Gairdner Awards honour groundbreaking medical research behind cancer, epilepsy and heart disease and malaria treatments. Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

A clip re: the Autism Genome Project that the Centre for Applied Genomics is undertaking.